Literature DB >> 18279483

Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?

S E Pålhagen1, M Carlsson, E Curman, J Wålinder, A-K Granérus.   

Abstract

OBJECTIVE: The aims were to study if the type and complexity of Parkinsonian symptoms, as well as treatment, could be related to the occurrence and severity of later depressive symptoms. Furthermore, the aim was to study if there is a different depressive symptomatology in Parkinson's disease (PD) patients compared with depressive illness in an age-matched group of patients with major depression but without Parkinson's disease.
METHODS: Eleven PD-patients with major depression (MD) were compared to 14 PD-patients without depression and to 12 MD patients without PD.
RESULTS: PD patients who later developed a depressive illness were younger at the debut of PD than patients without depression (P < 0.05). At inclusion the depressed PD patients were more disabled than PD patients without depression with higher level in the H&amp;Y scale (P<0.05), and they had more involuntary movements according to Unified Parkinson's Disease Rating Scale (UPDRS IV) (P < 0.01). A family history of depression was found in one third of the depressed non-parkinsonian patients but in none of the PD groups. Sleep disturbances were significantly more common among depressed PD patients than in PD patients without depression but even more common in depressed patients without PD.
CONCLUSIONS: Depressed PD patients had a longer duration of PD and more severe motor symptoms than PD patients without depression, although tremor as an initial symptom seemed to be more common in PD without a later depression. It cannot be excluded that depression in PD reflects a more advanced and widespread neurodegeneration, including serotonergic as well as dopaminergic neurons. Sleep disturbances is common and could be overlooked as an expression of depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279483     DOI: 10.1111/j.1600-0404.2007.00986.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  23 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 2.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

3.  Chronic stress and Parkinson's disease.

Authors:  Gonglin Hou; Rui Tian; Jiang Li; Ti-Fei Yuan
Journal:  CNS Neurosci Ther       Date:  2014-01       Impact factor: 5.243

4.  Stress exacerbates experimental Parkinson's disease.

Authors:  A M Hemmerle; J W Dickerson; J P Herman; K B Seroogy
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

5.  Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.

Authors:  Sven Pålhagen; Hongshi Qi; Björn Mårtensson; Jan Wålinder; Ann-Kathrine Granérus; Per Svenningsson
Journal:  J Neurol       Date:  2009-10-21       Impact factor: 4.849

Review 6.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 7.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

8.  HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

Authors:  Sven E Pålhagen; Stefan Ekberg; Jan Wålinder; Ann-Kathrine Granérus; Göran Granerus
Journal:  J Neurol       Date:  2009-05-10       Impact factor: 4.849

9.  Anxiety and depression in Parkinson's disease.

Authors:  Atbin Djamshidian; Joseph H Friedman
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.598

10.  Dispositional optimism, depression, disability and quality of life in Parkinson's disease.

Authors:  Annalisa Gison; Valentina Dall'Armi; Valentina Donati; Federica Rizza; Salvatore Giaquinto
Journal:  Funct Neurol       Date:  2014 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.